Skip to content
Screener

Veradermics MANE Business Segments — Interest Income

Similar metrics at other companies

Bicara Therapeutics logo
BCAXReportable Segment — Interest Income
$4.08M-18.6%
nCino, Inc. logo
NCNOReportable Segment — Interest Income
$366K-12.2%
DocuSign logo
DOCUReportable Segment — Interest Income
$8.73M-18.4%
UiPath logo
PATHReportable Segment — Interest Income
$10.4M-17.8%
YSS
YSSReportable Segment — Interest Income
$4.62M+754%
Intuitive Machines, Inc. logo
LUNRReportable Segment — Interest Income
$1.43M+0.8%

Other financials

Income statement

See full
Operating income-$29.9M-131%
Net income-$27.2M-120%
EPS (diluted)-$1.32+93.3%

Balance sheet

See full
Cash & equivalents$168.4M+419%
Total debt$4.0K
Total equity$390.6M+744%
Total assets$397.4M

Cash flow

See full
Operating cash flow-$21.2M-59.0%
CapEx--100%
Free cash flow-$21.2M-58.7%

Valuation

See full
Market cap$4.65B+269%

Returns & leverage

See full
Return on equity-28.7%
Current ratio59.1×

Where this comes from

Reported directly by Veradermics in its filing.

Tagged under the XBRL concept us-gaap:InvestmentIncomeInterest.

The source filing: Veradermics’s 10-Q, filed May 12, 2026.

Filed
May 12, 2026, 5:06 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001827635-26-000019

(1) For the three months ended March 31, 2026 other segment items include interest income of $2.5 million and investment accretion of $0.1 million. For the three months ended March 31, 2025, other segment items include interest income of $0.5 million.

Item 1. Condensed Consolidated Financial Statements (

FAQ

What is Veradermics's business segments — interest income?
Veradermics (MANE) reported business segments — interest income of $2.5M in Q1 2026.
How has Veradermics's business segments — interest income changed year-over-year?
Veradermics's business segments — interest income increased by 418.7% year-over-year, from $482K to $2.5M.
What does business segments — interest income mean?
This metric reflects the income earned from the company's cash, cash equivalents, and short-term investment portfolio. It represents the return on the company's idle capital held in interest-bearing accounts or securities. This is a non-operating income source that helps offset a portion of the company's operating expenses.

Ask your AI about Veradermics's business segments — interest income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude